Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

nelotanserin

Known as: 1-(3-(4-Bromo-1-Methyl-1H-Pyrazol-5-yl)-4-Methoxyphenyl)-3-(2,4-Difluorophenyl)Urea, Urea, N-(3-(4-Bromo-1-Methyl-1H-Pyrazol-5-yl)-4-Methoxyphenyl)-N'-(2,4-Difluorophenyl)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
G protein-coupled receptors (GPCRs), also known as 7-transmembrane receptors, are the single largest class of drug targets… Expand
Is this relevant?
2018
2018
 
Is this relevant?
Review
2017
Review
2017
Objective: To evaluate the safety and efficacy of nelotanserin in Lewy body dementia subjects experiencing visual hallucinations… Expand
Is this relevant?
Review
2017
Review
2017
Several drug classes are widely prescribed when difficulties with sleep induction or sleep maintenance occur, as is the case in… Expand
Is this relevant?
Review
2017
Review
2017
This article reviews current treatment strategies and recent advances for the Lewy body dementias (LBDs). Current available… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
2016
2016
Several agents are known to improve sleep induction and/or maintenance in patients with insomnia disorder. These include the… Expand
  • table 1
  • table 2
  • table 4
  • table 3
  • table 5
Is this relevant?
Review
2011
Review
2011
Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
5-Hydroxytryptamine (5-HT)(2A) receptor inverse agonists are promising therapeutic agents for the treatment of sleep maintenance… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • table 2
Is this relevant?
2010
2010
Insomnia affects a growing portion of the adult population in the U.S. Most current therapeutic approaches to insomnia primarily… Expand
Is this relevant?